Angel Broking is bullish on Dr Reddys Laboratories (DRL) and has recommended buy rating on the stock with a target of Rs 3,878 in its February 02, 2015 research report.
For 3QFY2015, Dr Reddy's Laboratories (DRL) posted marginally lower-than-expected numbers. The revenues came in at Rs 3,843cr (V/s an expected Rs 4,000cr), registering a yoy growth of 8.8%. Generic sales grew at 7.8% yoy, while the PSAI segment grew by 20.8% yoy. On the operating front, the EBIDTA came in at 23.0% V/s an expected 22.2% and V/s 27.6% in 3QFY2014, ie a yoy dip of 460bp. A higher R&D expenditure during the quarter (11.2% as a percentage of sales V/s 8.4% in 3QFY2014) adversely impacted margins. Further, the company posted an Adj PAT of Rs 575cr for the quarter V/s Rs 584cr in 3QFY2014, a yoy dip of 1.6%. We had estimated an Adj PAT of Rs 611cr for the quarter.
Revenues for the quarter came in at Rs 3,843cr (V/s an expected Rs 4,000cr), recording a yoy growth of 8.8%. Generic sales grew at 7.8% yoy, while the Pharmaceutical Services and Active Ingredients (PSAI) segment grew by 20.8% yoy. In the generic segment, the USA grew by 3.7% yoy, Europe by 4.6% yoy, India by 11.0% yoy, ROW by 82.3% yoy while Russia & CIS posted a dip of 10.0% yoy. On the operating front, the EBIDTA came in at 23.2% V/s an expected 22.2%, and V/s 27.6% in 3QFY2014, ie a yoy dip of 460bp. A higher R&D expenditure during the quarter (11.2% as a percentage of sales V/s 8.4% in 3QFY2014) adversely impacted margins. The company posted an Adj PAT of Rs 575cr for the quarter V/s Rs 584cr in 3QFY2014, a yoy dip of 1.6%. We had estimated an Adj PAT of Rs 611cr for the quarter.
Outlook and valuation: "We expect net sales to grow at a CAGR of 18.8% to Rs 18,657cr and adjusted EPS to record a 20.7% CAGR to Rs 184.7 over FY2014-16E. We recommend a Buy rating on the stock with a target price of Rs 3,878", says Angel Broking research report.
For all recommendations, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
To read the full report click here
Anda sedang membaca artikel tentang
Buy Dr Reddys Laboratories; target of Rs 3878: Angel
Dengan url
http://harmonisem.blogspot.com/2015/02/buy-dr-reddys-laboratories-target-of-rs.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Buy Dr Reddys Laboratories; target of Rs 3878: Angel
namun jangan lupa untuk meletakkan link
Buy Dr Reddys Laboratories; target of Rs 3878: Angel
sebagai sumbernya
0 komentar:
Posting Komentar